Crossmark

Cardiovascular risks and bleeding with non-vitamin K antagonist oral anticoagulant versus warfarin in patients with type 2 diabetes: a tapered matching cohort study

Crossref DOI link: https://doi.org/10.1186/s12933-020-01152-y

Published Online: 2020-10-10

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Dahai http://orcid.org/0000-0002-8449-7725
Zhao, Zhanzheng

Simmons, David
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81873611)
License Information

Text and Data Mining valid from 2020-10-10

Version of Record valid from 2020-10-10
More Information

Article History

Received: 16 June 2020

Accepted: 5 October 2020

First Online: 10 October 2020

Ethics approval and consent to participate

: The study was approved by South West—Exeter Research Ethics Committee (REC reference: 17/SW/0001).

: If the manuscript is accepted, we approve it for publication in Cardiovascular Diabetology.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below